Professor Francois Spertini, founder of Anergis, supports the Company in medical and scientific matters and is the chairman of the Scientific Advisory Board as well as vice-chairman of the Board of Directors. Dr Spertini has been instrumental in all developments and progress of the Company since its inception. Dr. François Spertini, MD, is currently Associate Professor of Medicine at the Faculty of Biology and Medicine of the University of Lausanne and chief-physician at the Centre Hospitalier Universitaire Vaudois in Lausanne. He is Board Certified in Internal Medicine and in Allergology and Clinical Immunology. Dr. Spertini studied medicine at the University of Lausanne. He developed strong background in immunology during successive fellowships at the University of Geneva and at Harvard Medical School, Boston, before establishing his group in Lausanne in 1992. He focuses on immune response to tuberculosis and malaria, as well as on the downregulation of the allergic response. He has led several early phase clinical trials on novel vaccine candidates in the field of tuberculosis and malaria. He was President of the Swiss Society of Allergology and Immunology (2001-2003) and is involved in several scientific associations.    

 immunology